Literature DB >> 12126986

Efficacy of elevated body swing test in the early model of Parkinson's disease in rat.

Mehrdad Roghani1, Gila Behzadi, Tourandokht Baluchnejadmojarad.   

Abstract

Animal models of Parkinson's disease (PD) with partial damage of the dopaminergic nigrostriatal system are very suitable for the development of neuroprotective and neurotrophic treatment strategies. Although drug-induced rotational behavior has conventionally been used for the analysis of lesioned animals, a pure behavioral test that can evaluate such animals in a drug-free state may better reflect a more natural response following lesion. In this study, an early model of PD was developed by intrastriatal injection of 12.5 microg of 6-hydroxydopamine (6-OHDA) into the left striatum. Apomorphine-induced rotational and drug-free elevated body swing behaviors were evaluated. The results of the rotational test revealed a very significant contralateral turning in the rats of the lesion group (L+V) compared with the sham-operated group (SH) (P<.0001). In addition, the results of elevated body swing test (EBST) showed a significant difference between the L+V and SH groups in the second (P<.01) and fourth weeks (P<.05) after surgery. Further analysis of correlation for the net number of rotations versus the net number of swings revealed a significant and positive correlation (r=.52) in the second week in the L+V group, but no such correlation was observed in the fourth week (r=.24). Taken together, it is concluded that despite a poor correlation at fourth week postlesion, EBST itself may be appropriate and sensitive for the evaluation of motor asymmetry in the unilateral model of early PD in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126986     DOI: 10.1016/s0031-9384(02)00753-9

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  11 in total

1.  Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.

Authors:  Joanna A Korecka; Elizabeth B Moloney; Ruben Eggers; Barbara Hobo; Sanny Scheffer; Nienke Ras-Verloop; R Jeroen Pasterkamp; Dick F Swaab; August B Smit; Ronald E van Kesteren; Koen Bossers; Joost Verhaagen
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

2.  Quantifying muscle alterations in a Parkinson's disease animal model using electromyographic biomarkers.

Authors:  Pablo Y Teruya; Fernando D Farfán; Álvaro G Pizá; Jorge H Soletta; Facundo A Lucianna; Ana L Albarracín
Journal:  Med Biol Eng Comput       Date:  2021-07-23       Impact factor: 2.602

3.  The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.

Authors:  Nida Jamali-Raeufy; Zahra Mojarrab; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Javad Fahanik-Babaei; Mina Goudarzi
Journal:  Metab Brain Dis       Date:  2020-02-03       Impact factor: 3.584

4.  Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.

Authors:  Zahra Kiasalari; Mohsen Khalili; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

5.  Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.

Authors:  Eduard Bentea; Anke Van der Perren; Joeri Van Liefferinge; Anissa El Arfani; Giulia Albertini; Thomas Demuyser; Ellen Merckx; Yvette Michotte; Ilse Smolders; Veerle Baekelandt; Ann Massie
Journal:  Front Behav Neurosci       Date:  2015-03-31       Impact factor: 3.558

6.  New neurons use Slit-Robo signaling to migrate through the glial meshwork and approach a lesion for functional regeneration.

Authors:  N Kaneko; V Herranz-Pérez; T Otsuka; H Sano; N Ohno; T Omata; H B Nguyen; T Q Thai; A Nambu; Y Kawaguchi; J M García-Verdugo; K Sawamoto
Journal:  Sci Adv       Date:  2018-12-12       Impact factor: 14.136

7.  Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β Signaling.

Authors:  Xing-Zhi Guo; Chang Shan; Yan-Fang Hou; Geng Zhu; Bei Tao; Li-Hao Sun; Hong-Yan Zhao; Guang Ning; Sheng-Tian Li; Jian-Min Liu
Journal:  Front Mol Neurosci       Date:  2018-09-27       Impact factor: 5.639

8.  (-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice.

Authors:  Shih-Chang Hsueh; Daniela Lecca; Nigel H Greig; Jia-Yi Wang; Warren Selman; Barry J Hoffer; Jonathan P Miller; Yung-Hsiao Chiang
Journal:  Cell Transplant       Date:  2019-06-10       Impact factor: 4.064

9.  Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats.

Authors:  Ilaria Rosa; Davide Di Censo; Brigida Ranieri; Giuseppe Di Giovanni; Eugenio Scarnati; Marcello Alecci; Angelo Galante; Tiziana Marilena Florio
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

10.  The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson's Disease Can Be Affected by Toxoplasma gondii Infection.

Authors:  Mahnaz Taherianfard; Moslem Riyahi; Mostafa Razavi; Zahedeh Bavandi; Narges Eskandari Roozbahani; Mohammad Mehdi Namavari
Journal:  Biomed Res Int       Date:  2020-05-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.